91 related articles for article (PubMed ID: 502675)
1. [Antibodies in the secretion can modify the adhesiveness of bacteria on mucous membrane areas].
Svanborg-Edén C
Lakartidningen; 1979 Oct; 76(40):3400-1. PubMed ID: 502675
[No Abstract] [Full Text] [Related]
2. Netherlands Society for Microbiology, Medical Section, and Nederlandse Vereniging voor Laboratoriumartsen. Joint symposium, Amsterdam, 15 May 1986. Pathogenic bacteria and mucous membrane infections. The role of surface components. Abstracts.
Antonie Van Leeuwenhoek; 1986; 52(5):445-66. PubMed ID: 3789708
[No Abstract] [Full Text] [Related]
3. Bladder defense mechanism.
Mulholland SG; Parsons CL; Shrom SH; Murphy JJ
Trans Am Assoc Genitourin Surg; 1976; 68():83-6. PubMed ID: 801214
[TBL] [Abstract][Full Text] [Related]
4. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa.
Ramos HC; Rumbo M; Sirard JC
Trends Microbiol; 2004 Nov; 12(11):509-17. PubMed ID: 15488392
[TBL] [Abstract][Full Text] [Related]
5. Antibody-cleaving neisseria.
Sparling PF
N Engl J Med; 1978 Nov; 299(18):1011. PubMed ID: 692618
[No Abstract] [Full Text] [Related]
6. [The adherence of bacteria to mucosal surfaces (author's transl)].
Beachey EH
Immun Infekt; 1982 Mar; 10(2):51-6. PubMed ID: 6121752
[TBL] [Abstract][Full Text] [Related]
7. Human milk: Defense against infection.
Hanson LA; Söderström T
Prog Clin Biol Res; 1981; 61():147-59. PubMed ID: 6798576
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study on spreading of surface infections. II. Tracing of inoculated organisms by scanning of the mucous membrane].
Matsuyama T
Nihon Saikingaku Zasshi; 1975 Jan; 30(1):117. PubMed ID: 1240183
[No Abstract] [Full Text] [Related]
9. [Review on opportunistic infection].
Ozawa A
Nihon Saikingaku Zasshi; 1982 Jul; 37(4):739-56. PubMed ID: 6757471
[No Abstract] [Full Text] [Related]
10. The determinants of microbial pathogenicity.
Smith H
Zentralbl Bakteriol Orig A; 1974; 227(1-4):136-45. PubMed ID: 4154580
[No Abstract] [Full Text] [Related]
11. Adhesion inhibition by antibodies.
Svanborg-Edén C; Mårild S; Korhonen TK
Scand J Infect Dis Suppl; 1982; 33():72-8. PubMed ID: 6127804
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of pathogenicities of bacteria.
Arai T
Kitasato Arch Exp Med; 1982 Jun; 55(1-2):1-9. PubMed ID: 7169764
[No Abstract] [Full Text] [Related]
13. Comparative in vivo analysis of IgA- and IgG-mediated mucosal defense against bacterial pathogens.
Steinmetz I
Behring Inst Mitt; 1997 Feb; (98):53-5. PubMed ID: 9382769
[No Abstract] [Full Text] [Related]
14. Vaccination by aerosols: modulation of clearance mechanisms in the lung.
Hensel A; Lubitz W
Behring Inst Mitt; 1997 Feb; (98):212-9. PubMed ID: 9382742
[TBL] [Abstract][Full Text] [Related]
15. The struggle for iron: gastrointestinal microbes modulate the host immune response during infection.
Markel TA; Crisostomo PR; Wang M; Herring CM; Meldrum KK; Lillemoe KD; Meldrum DR
J Leukoc Biol; 2007 Feb; 81(2):393-400. PubMed ID: 17255516
[TBL] [Abstract][Full Text] [Related]
16. Bladder defense mechanisms against urinary tract infections.
Schaeffer AJ
Semin Urol; 1983 May; 1(2):106-13. PubMed ID: 6382529
[No Abstract] [Full Text] [Related]
17. Mucosal immunity (a review).
Kövesi G
Acta Microbiol Immunol Hung; 1994; 41(3):221-39. PubMed ID: 7697317
[No Abstract] [Full Text] [Related]
18. Sputum cell dynamics in bacterial exacerbations of chronic bronchial disease.
Medici TC; Chodosh S
Arch Intern Med; 1972 Apr; 129(4):597-603. PubMed ID: 5019450
[No Abstract] [Full Text] [Related]
19. Antimicrobial resistance and immunosuppression.
Lagrange PH
J Toxicol Clin Exp; 1992 Nov; 12(6-7):365-84. PubMed ID: 1300368
[No Abstract] [Full Text] [Related]
20. Phagocytosis in mucosal defence.
Forsgren A
Rhinology; 1983 Sep; 21(3):213-5. PubMed ID: 6635470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
